Wei-Min Mao

Wei-Min Mao

Auto-generated profile, based on publicly available information

Wei-Min Mao

Cancer Research Institute, Zhejiang Cancer Hospital & Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology of Zhejiang Province, Hangzhou, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011
Verified
Journal Article
Closed access
WMWei-Min Mao
Wei-Min Mao
WZWei-Hui Zheng
Wei-Hui Zheng
ZLZhi-Qiang Ling
Zhi-Qiang Ling

20 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDan Su
Dan Su
XZXinming Zhou
Xinming Zhou
QCQixun Chen
Qixun Chen
YJYouhua Jiang
Youhua Jiang
XYXun Yang
Xun Yang
WMWeimin Mao
Weimin Mao
Nomogram has demonstrated its capability in individualized estimates of survival in diverse cancers. Here we retrospectively investigated 1195 patients with esophageal squamous-cell carcinoma (ESCC) who underwent radical esophagectomy at Zhejiang Cancer Hospital in Hangzhou, China. We randomly assigned two-thirds of the patients to a training cohort (n = 797) and one-third to a validation cohort (n = 398). Cox proportional hazards regression analyses were performed using the training cohort, and a nomogram was developed for predicting 3-year and 5-year overall survival rates. Multivariate analysis identified tumor length, surgical approach, number of examined lymph node, number of positive lymph node, extent of positive lymph node, grade, and depth of invasion as independent risk factors for survival. The discriminative ability of the nomogram was externally determined using the validation cohort, showing that the nomogram exhibited a sufficient level of discrimination according to the C-index (0.715, 95% CI 0.671–0.759). The C-index of the nomogram was significantly higher than that of the sixth edition (0.664, P-value<0.0001) and the seventh edition (0.696, P-value<0.0003) of the TNM classification. This study developed the first nomogram for ESCC, which can be applied in daily clinical practice for individualized survival prediction.

10 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JWJiwen Wang
Jiwen Wang
JWJinyu Wei
Jinyu Wei
XXXiaoling Xu
Xiaoling Xu
WPWenting Pan
Wenting Pan
YGYunxia Ge
Yunxia Ge
WMWeimin Mao
Weimin Mao
China was one of the countries with highest esophageal squamous cell carcinoma (ESCC) incidence and mortality worldwide. Alcohol drinking has been identified as a major environmental risk-factor related to ESCC. The alcohol dehydrogenase (ADH) family are major enzymes involved in the alcohol-metabolizing pathways, including alcohol dehydrogenase 1B (ADH1B) and ADH1C. Interestingly, ADH1B and ADH1C genes locate tandemly with ADH7 in a genomic segment as a gene cluster, and are all polymorphic. Several ESCC susceptibility single nucleotide polymorphisms (SNPs) of the ADH1B-ADH1C-ADH7 cluster have been identified previously through a genome-wide association study (GWAS). In the study, we examined the association between five ADH1B-ADH1C-ADH7 cluster SNPs (rs1042026, rs17033, rs1614972, rs1789903 and rs17028973) and risk of developing ESCC. Genotypes were determined in two independent case-control sets from two regions of China. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression. Our data demonstrated that these ADH1B-ADH1C-ADH7 cluster SNPs confer susceptibility to ESCC in these two case-control sets, which were consistent to results of the previous GWAS.

1 April 2012 in Zhonghua Zhong Liu Za Zhi [chinese Journal of Oncology]
Verified
Journal Article
Closed access
PCPeng-Cheng Chen
Peng-Cheng Chen
QCQi-Xun Chen
Qi-Xun Chen
XNXing-Hao Ni
Xing-Hao Ni
XZXin-Ming Zhou
Xin-Ming Zhou
WMWei-Min Mao
Wei-Min Mao
To analyze the clinicopathological characteristics and prognosis of a rare histological type of esophageal cancer-sarcomatoid carcinoma. Clinicopathological data of 31 patients with esophageal sarcomatoid carcinoma who underwent surgery in the Department of Thoracic Surgery of Zhejiang Cancer Hospital from Jan 2000 to Dec 2009 were collected and analyzed. The survival analysis was performed using Kaplan-Meier method. All the patients underwent surgery. Of the 31 patients, one received preoperative chemoradiotherapy and postoperative chemotherapy, and 8 received postoperative chemotherapy. All the tumors were located in the middle or lower esophagus. Microscopically, the tumors were composed of both carcinomatous and sarcomatous components, and there was a transition between the two components, but no obvious heterogenous elements such as osteosarcoma, chondrosarcoma or rhabdomyosarcoma were found. In the carcinomatous components, positive expression of CK and EMA was found in all the 31 cases, and positive expression of vimentin in 5 of the 31 cases. In the sarcomatous components, positive expression of CK, EMA and vimentin was found in 29, 28 and 23 cases, respectively. The 1-, 3-, and 5-year survival rates were 80.6%, 55.9% and 33.4%, respectively, and the median survival time was 40 months. Esophageal sarcomatoid carcinoma is a particular type of esophageal malignancy with unique clinicopathological features. The diversity and complexity of the carcinomatous and sarcomatous components and their potential of transformation and differentiation lead to different prognosis from each other.

1 December 2011
Verified
Journal Article
Closed access
YXYa-Pin Xu
Ya-Pin Xu
WMWei-Min Mao
Wei-Min Mao
SMSheng Lin Ma
Sheng Lin Ma
YJYou-Hua Jiang
You-Hua Jiang
JLJin-Shi Liu
Jin-Shi Liu
XSXiao-Jiang Sun
Xiao-Jiang Sun

1 May 2010
Verified
Journal Article
Closed access
HZHong-Guang Zhao
Hong-Guang Zhao
YHYan-Jun Hu
Yan-Jun Hu
WMWei-Min Mao
Wei-Min Mao
XZXin-Ming Zhou
Xin-Ming Zhou
QCQi-Xun Chen
Qi-Xun Chen
YJYou-Hua Jiang
You-Hua Jiang